Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 11 Oct 24 424B3 Prospectus supplement
- 4 Oct 24 424B3 Prospectus supplement
- 26 Sep 24 424B3 Prospectus supplement
- 2 Aug 24 424B3 Prospectus supplement
- 8 Jul 24 EFFECT Notice of effectiveness
- 5 Jul 24 424B3 Prospectus supplement
- 27 Jun 24 S-1/A IPO registration (amended)
-
5 Jun 24 S-1/A IPO registration (amended)
- 22 May 24 424B3 Prospectus supplement
- 6 May 24 S-1 IPO registration
CERO similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Amendment No. 1 to Registration Statement (No. 333-279156) on Form S-1 of CERo Therapeutics Holdings, Inc. of our report dated April 1, 2024, relating to the financial statements of CERo Therapeutics, Inc., appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the caption “Experts” in such Prospectus.
/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
June 5, 2024